Perthera, Inc. is a therapeutic intelligence company headquartered in Burlington, North Carolina, that advances precision oncology and personalized medicine through its proprietary testing and analysis platform.
Subscribe to see Perthera, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Perthera, Inc. is a healthcare company headquartered in Mclean, United States. It has raised at least $16.5M across the 4 funding rounds on record. Its most recent funding round raised $4.5M in March 2022. Xcout tracks 12 named people at Perthera, Inc., including Gautam Priya (Chief Technology Officer).
As of 16 November 2026. Source: Xcout Intel.
6 more named people on record for Perthera, Inc., with roles, board committees and tenure — see the full roster →
At least $16.5M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.5M | — | |
| SEC Form D filing | $2.1M | — | |
| SEC Form D filing | $750,000 | — | |
| Series A | $9.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Perthera, Inc.'s closest competitors — see the full list of competitors and alternatives →
Tempus AI, Inc. is an American health technology company founded in 2015 in Chicago, Illinois. The company builds a practical platform to gather and analyze clinical and molecular data, empowering physicians to make data-driven patient care decisions.
EarlyDiagnostics, also known as EarlyDx, is a clinical-stage precision diagnostics company that develops non-invasive liquid biopsy technologies and genomics platforms for early cancer detection.
Innocras is a genomic analysis and cancer big data company founded in South Korea by physician-scientists from KAIST, maintaining research and corporate presence in both the United States and Korea. The company specializes in advanced cancer diagnostics and genomic technology to support precision oncology.
ArcherDX, Inc. is a molecular technology company located in Boulder, Colorado, dedicated to developing breakthrough solutions for personalized genomic medicine. The company creates advanced assays and diagnostic tools that advance oncology research and clinical applications.
Predicine Holdings Ltd provides next-generation liquid biopsy platforms and molecular profiling services for cancer research and precision medicine. The company utilizes proprietary blood- and urine-based assays to analyze circulating tumor DNA and RNA, serving biopharmaceutical partners and clinical researchers in oncology drug development and clinical trials.
Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Perthera, Inc.? Suggest a correction · Work at Perthera, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.